Johns Hopkins Medicine Office of Continuing Medical Education
Skip Navigation.
How ToAbout CMECME CalendarOnline/EnduringProgramsResources & DownloadsContact & Travel InformationBlog
CME Online
Forgot your password?

Not Registered yet?

Create a new account.

80022896: Today's Patient in Non-Small-Cell Lung Cancer

July 12, 2010 - November 1, 2010
  • Send to Colleague
  • Back to List

Course Description


Lung cancer remains the leading cause of cancer mortality in the United States. Despite advances in therapeutic options, only 15% of patients with lung cancer survive beyond 5 years. However, the identification of markers is improving these grim statistics. Recent data suggests there is a correlation between lung cancer histologic subtype and treatment outcomes. Tumor gene expression can now be used to predict which patients would respond to targeted therapy. Personalized therapy for patients with non–small-cell lung cancer (NSCLC) is customizing treatment based on genomics as well as tumor histology. Considering these advances, our interactive educational activity is designed to bring the participant into a virtual clinical setting allowing the application of this knowledge. Video cases, interactive decision points, and expert rationale will guide the participant through this activity.

Learning Objectives


Upon the conclusion of this activity, the participant should be able to:
•Identify how histologic subtypes of NSCLC can guide the selection of chemotherapy.
•Develop strategies to individualize therapy based on NSCLC histology.
•Determine appropriate maintenance therapy for patients with advanced NSCLC.
The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

Click Here for more information and to access this activity

Policy On Speaker And Provider Disclosure

It is the policy of the Johns Hopkins University School of Medicine that the speaker and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the activity handout materials.

Event Information
Enduring material, location does not apply
,
Directions

Target Audience(s)

This activity is designed for oncologists, hematologists, and oncology nursing professionals. No prerequisites required.

Course Director

David Ettinger

Contact Info

General Info: 410.502.9634

Mailing Address:
Johns Hopkins University School
of Medicine
Thomas B. Turner Building
720 Rutland Avenue, Room 20
Baltimore, Maryland 21205-2195

Email Us

© 2010 Johns Hopkins University
School of Medicine | Office of Continuing Medical Education
Home | Privacy Policy | Sitemap
Managed Hosting by PEER 1
HTML to PDF conversion by ABCpdf.NET